Skip to main content
. 2017 Aug 2;12(8):e0182175. doi: 10.1371/journal.pone.0182175

Table 1. Lymphoma/T-leukemia development in secondary recipients.

Cell doses T-cell lymphoma/leukemia incidence Latency (days)
Experiment #1
4x105 5/5 14–18
4x104 5/5 14–20
4x103 5/5 20–24
400 5/5 22–25
40 2/5 35–38
Experiment #2
4x104 5/5 15–18
4x103 5/5 18–26
400 5/5 24–28
40 0/5
Experiment #3
4x104 5/5 14–16
4x103 5/5 14–20
400 5/5 20–24
40 1/5 34

Indicated numbers of lymphoma cells were transplanted into sublethally irradiated WT recipients (n = 5 per group). Lymphoma development in the recipients was monitored. Similar results were obtained in three independent experiments.